Postinfectious Irritable Bowel Syndrome and Gelsectan

计划入组 275 人 · 首次发布于 2021 年 9 月 16 日

Colilen IBS- Irritable Bowel Syndrome- adults-Phase III

计划入组 140 人

Irritable Bowel Syndrome Hypnotherapy

计划入组 89 人 · 首次发布于 2010 年 11 月 25 日

Otilonium

C₂₉H₄₃N₂O₄

Escherichia coli

Fenoverine

C₂₆H₂₅N₃O₃S

ALPORT SYNDROME FOUNDATION

United States

International Bowel Ultrasound Group e.V.

Germany

International Rett Syndrome Foundation

United States

Anatara Lifesciences Nears Completion of Stage 2 Recruitment for GaRP-IBS Trial

Genetic Variants Influence Diet Effectiveness in Irritable Bowel Syndrome

FDA Approves First Pediatric Treatment for Irritable Bowel Syndrome with Constipation